PO.ET02.14 · 实验与分子治疗

用于阐明肿瘤微环境中T细胞功能的精准FISH/IF多组学检测panel的开发与应用

Development and utility of precision FISH/IF multiomic panel to elucidate T cell functionality in the tumor microenvironment

海报缩略图:用于阐明肿瘤微环境中T细胞功能的精准FISH/IF多组学检测panel的开发与应用
编号 5832 展板 1 时间 4/21 02:00–05:00 区域 Section 17 主讲 Chandler Callaway, PhD
分会场 Tumor Microenvironment, Multispecifics, and Immunomodulation
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Anushka Dikshit1, Chandler Callaway2, Sukhbir Lulla1, Will Paces2, Alan Busar2, Sara Wells3, Mandy Bell2, Lauren Matelski4, Sharel Figueredo1, Lenka Sinik4

1ACD, a Bio-Techne Brand, Newark, CA,2Flagship Biosciences, Broomfield, CO,3Flagship biosciences, Bloomfield, CO,4Flagship Biosciences, Bloomfield, CO

摘要 Abstract

中文摘要
免疫组织化学(IHC)是一种广泛用于可视化目标组织中生物标志物表达的工具。然而,并非所有生物标志物都适合通过IHC进行研究,包括分泌因子,如细胞因子。在这些情况下,原位杂交(ISH)可能是一种合适的替代方法。IHC和ISH方法的结合可以在同一多组学检测中研究蛋白质和RNA靶点,相较于传统检测提供更大的应用价值和灵活性。此外,可应用图像和空间分析来阐明同一样本中RNA和蛋白质生物标志物的共定位、邻近性和空间关系。Flagship Biosciences与Advanced Cell Diagnostics(ACD)合作,正在开发一种多重IHC/ISH荧光检测,旨在识别和表征癌症背景下的T淋巴细胞亚群。使用RNAscope™ Multiomic LS检测,我们在检测CD8、CD3和Ki67蛋白的同时检测了IL4、IFNG和GZMB的RNA表达,以基于生物标志物表达谱评估不同T细胞亚群的激活和功能状态。在此,我们在一组来自健康和非小细胞肺癌受试者的FFPE肺样本上展示了这一分析的能力。我们的方法和分析凸显了空间多组学检测在连接免疫生物学与癌症研究方面的潜力。所生成的数据可能有助于肿瘤表型分析、监测治疗反应,或更好地理解肿瘤微环境内的免疫细胞动态。
查看英文原文 English abstract
Immunohistochemistry (IHC) is a widely utilized tool for visualizing biomarker expression in tissues of interest. However, not all biomarkers are amenable to investigation by IHC, including secreted factors, such as cytokines. In these cases, in situ hybridization (ISH) may be a suitable alternative. The combination of IHC and ISH approaches allows for investigation of protein and RNA targets in the same multiomic assay, offering greater utility and flexibility than traditional assays. Furthermore, image and spatial analyses can be applied to elucidate the colocalization, proximity, and spatial relationship of RNA and protein biomarkers in the same sample. Flagship Biosciences, in collaboration with Advanced Cell Diagnostics (ACD), is developing a multiplex IHC/ISH fluorescent, which aims to identify and characterize subsets of T lymphocytes in the context of cancer. Using the RNAscope™ Multiomic LS assay we detected CD8, CD3, and Ki67 proteins alongside IL4 , IFNG , and GZMB RNA expression to assess the activation and functional state of different T cell subsets based on biomarker expression profiles. Here, we demonstrate the capacity of this analysis on a set of FFPE lung samples from healthy and non-small cell lung cancer subjects. Our approach and analysis highlights the potential of spatial multiomics assays to bridge immunobiology with cancer research. Data generated could prove useful for phenotyping tumors, monitoring therapy response, or better understanding immune cell dynamics within the tumor microenvironment.
利益披露 Disclosure
A. Dikshit, ACD, a Bio-techne brand Employment. C. Callaway, Flagship biosciences Employment. S. Lulla, ACD, a Bio-techne.com Employment. W. Paces, Flagship Biosciences Employment. A. Busar, Flagship Biosciences Employment. S. Wells, Flagship Biosciences Employment. M. Bell, Flagship Biosciences Employment. L. Matelski, Flagship Biosciences Employment. L. Sinik, Flagship Biosciences Employment.

← 返回 AACR 2026 检索